The pharmacologic approach to the treatment of shock. II. Diagnosis of shock and the plan of treatment.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D001803:Blood Transfusion; D002302:Cardiac Output; D004927:Escherichia coli Infections / Q000150:complications; D006321:Heart / Q000503:physiopathology; D006801:Humans; D007239:Infections / Q000150:complications; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D018805:Sepsis / Q000628:therapy; D012769:Shock / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012770:Shock, Cardiogenic / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy; D012774:Shock, Traumatic / Q000188:drug therapy / Q000628:therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014690:Venous Pressure
D000305:Adrenal Cortex Hormones; D013566:Sympathomimetics; D014665:Vasodilator Agents; D007612:Kanamycin; D009638:Norepinephrine; D008775:Methylprednisolone